Trials / Conditions / Adult Acute Myeloid Leukemia With t(9;11)(p22;q23); MLLT3-MLL

Adult Acute Myeloid Leukemia With t(9;11)(p22;q23); MLLT3-MLL

9 registered clinical trials studyying Adult Acute Myeloid Leukemia With t(9;11)(p22;q23); MLLT3-MLL.

Status	Trial	Sponsor	Phase
Completed	Cytarabine With or Without SCH 900776 in Treating Adult Patients With Relapsed Acute Myeloid Leukemia NCT01870596	National Cancer Institute (NCI)	Phase 2
Completed	Tipifarnib in Treating Older Patients With Acute Myeloid Leukemia NCT01361464	National Cancer Institute (NCI)	Phase 2
Terminated	Azacitidine, Mitoxantrone Hydrochloride, and Etoposide in Treating Older Patients With Poor-Prognosis Acute My NCT01260714	National Cancer Institute (NCI)	Phase 1
Completed	Lenalidomide, Cytarabine, and Idarubicin in Treating Patients With Acute Myeloid Leukemia NCT01132586	National Cancer Institute (NCI)	Phase 1
Completed	Azacitidine With or Without Entinostat in Treating Patients With Myelodysplastic Syndromes, Chronic Myelomonoc NCT00313586	National Cancer Institute (NCI)	Phase 2
Completed	Tipifarnib and Bortezomib in Treating Patients With Acute Leukemia or Chronic Myelogenous Leukemia in Blast Ph NCT00383474	National Cancer Institute (NCI)	Phase 1
Completed	Belinostat and Azacitidine in Treating Patients With Advanced Hematologic Cancers or Other Diseases NCT00351975	National Cancer Institute (NCI)	Phase 1
Completed	Sorafenib in Treating Patients With Refractory or Relapsed Acute Leukemia, Myelodysplastic Syndromes, or Blast NCT00217646	National Cancer Institute (NCI)	Phase 1
Completed	Tacrolimus and Mycophenolate Mofetil With or Without Sirolimus in Preventing Acute Graft-Versus-Host Disease i NCT00105001	Fred Hutchinson Cancer Center	Phase 2